The 3 best performing ASX shares in the week of 7 November 2022
Marc Kennis, November 14, 2022
The 3 best performing ASX shares in the week of 7 November 2022
The 3 best performing ASX shares of the week starting 7 November 2022 were Invictus Energy (ASX:IVZ), up 108.7%, Aeris Resources (ASX:AIS), up 57.8%, and Novatti Group (ASX:NOV), up 43.2%.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
1. Invictus Energy (ASX:IVZ)
Industry: Energy
Invictus Energy (ASX:IVZ) is an independent upstream oil and gas company. The company is opening rift basins in onshore Africa – the Cabora Bassa Basin – in northern Zimbabwe through a high impact exploration program.
Market Cap: $210m
12 month high / low: $0.10 – $0.36
2. Aeris Resources (ASX:AIS)
Industry: Resources
Aeris Resources (ASX:AIS) is a diversified mining and exploration company listed on the Australian Securities Exchange and headquartered in Brisbane, Queensland. During the year the company is involved in production and sale of copper, gold and silver and the exploration for copper and gold.
Market Cap: $349m
12 month high / low: $0.275 – $1.20
3. Novatti Group (ASX:NOV)
Industry: Industrials
Novatti Group (ASX:NOV) rounds out our 3 best performing ASX shares this week. NOV is a payment processing platform that facilitates mobile and alternative financial payments solutions and services.
Market Cap: $92m
12 month high / low: $0.15 – $0.43
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Recent Posts
Rule of 72: Here’s how investors can use it to their advantage
Here’s why The Rule of 72 might be useful to consider when investing in Stocks Investing in stocks can be…
Novo Nordisk (CPH: NOVO-B): It’s not all smooth sailing for the US$400bn company behind obesity drug Ozempic
Not many 100-year old healthcare stocks see a sudden 30% jump in sales in one year, but Novo Nordisk (CPH:…
Bapcor (ASX:BAP): Its been a horror week with a 3rd profit downgrade in less than a year
This week investors in Bapcor (ASX:BAP) saw a 3rd profit downgrade in less than a year and its CEO-elect walk…